The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, ahead of a planned fall vaccination campaign to shore up immune defenses against the virus.

The so-called bivalent vaccine is directed against both the original strain of SARS-CoV-2, the virus that causes Covid-19, and the first Omicron variant, also known as BA.1, which drove large waves of infection over the winter.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tense day in France for Macron’s gamble over retirement bill

France’s showdown over a bill raising the retirement age from 62 to 64 heads…

‘It’s a start’: People in Minneapolis greet the Chauvin conviction with mixed emotions

MINNEAPOLIS — When Susan Scalf and Amy Powers arrived outside the Hennepin…

Mattel Sales Rise as Demand for Toys Remains Strong

Mattel Inc. reported sales grew 19% to more than $1 billion in…

Polio vaccine coverage is as low as 37% in N.Y. county where paralysis case was found

Low polio vaccination rates plus the presence of the virus in wastewater…